Citation Impact
Citing Papers
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
2015 StandoutNobel
Characterization of MicroRNA Expression Levels and Their Biological Correlates in Human Cancer Cell Lines
2007 StandoutNobel
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
2022 StandoutNobel
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
2004 StandoutScience
SOX5/6/21 Prevent Oncogene-Driven Transformation of Brain Stem Cells
2017
Intratumor microvessel density as a prognostic factor in cancer.
1995
Feedback Circuit among INK4 Tumor Suppressors Constrains Human Glioblastoma Development
2008
The EGLN-HIF O 2 -Sensing System: Multiple Inputs and Feedbacks
2017 StandoutNobel
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
Modeling Adult Gliomas Using RCAS/t-va Technology
2009
Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma
2015
Interleukin-1 Regulates the Expression of Sphingosine Kinase 1 in Glioblastoma Cells
2008
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Isolated Cervical Juvenile Xanthogranuloma in Childhood
2001
Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma.
1996
Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
2010
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Multistage Nanoparticles for Improved Delivery into Tumor Tissue
2012 StandoutNobel
Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma
2004
Overexpression of the EGF Receptor and p53 Mutations are Mutually Exclusive in the Evolution of Primary and Secondary Glioblastomas
1996
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Phosphatase and tensin homolog deleted on chromosome 10 regulates sensory cell proliferation and differentiation of hair bundles in the mammalian cochlea
2010 StandoutNobel
Pituicytoma: Report of Two Cases and Clues Regarding Histogenesis
2004
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
A Role for Fibrillar Collagen Deposition and the Collagen Internalization Receptor Endo180 in Glioma Invasion
2010
Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization
2005
AMPA receptors promote perivascular glioma invasion via β1 integrin–dependent adhesion to the extracellular matrix
2008
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Detection of “oncometabolite” 2-hydroxyglutarate by magnetic resonance analysis as a biomarker of IDH1/2 mutations in glioma
2012
Neuroblastoma: biological insights into a clinical enigma
2003 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Stem cells find their niche
2001 StandoutNature
Controlling the morphology and outgrowth of nerve and neuroglial cells: The effect of surface topography
2017
VEGF-mediated tumour angiogenesis: a new target for cancer therapy
1995
P2Y12receptor‐mediated integrin‐β1 activation regulates microglial process extension induced by ATP
2010
Dynamic Quantitative Intravital Imaging of Glioblastoma Progression Reveals a Lack of Correlation between Tumor Growth and Blood Vessel Density
2013
Loss of ATM/Chk2/p53 Pathway Components Accelerates Tumor Development and Contributes to Radiation Resistance in Gliomas
2010
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Mimicking white matter tract topography using core–shell electrospun nanofibers to examine migration of malignant brain tumors
2013
Glioblastoma‐derived tumorospheres identify a population of tumor stem‐like cells with angiogenic potential and enhanced multidrug resistance phenotype
2006
Epidemiology of Brain Tumors
2007
Clinical Applications of Research on Angiogenesis
1995 Standout
Signaling—2000 and Beyond
2000 Standout
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
2013 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Malignant Gliomas in Adults
2008 Standout
The MDM2 gene amplification database
1998
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Tumor microenvironment and progression
2011
The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey
2008 StandoutNobel
Juvenile Xanthogranulomas in the First Two Decades of Life: A Clinicopathologic Study of 174 Cases With Cutaneous and Extracutaneous Manifestations
2003 Standout
Regulators of G-Protein Signaling 3 and 4 (RGS3, RGS4) Are Associated with Glioma Cell Motility
2004
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Flavopiridol downregulates hypoxia-mediated hypoxia-induciblefactor-1α expression in human glioma cells by a proteasome-independentpathway: Implications for in vivo therapy
2005
Low-level microsatellite instability phenotype in sporadic glioblastoma multiforme
2004
Histology-Based Expression Profiling Yields Novel Prognostic Markers in Human Glioblastoma
2005
Neuroblastoma
2007 Standout
The Long Non-coding RNA HIF1A-AS2 Facilitates the Maintenance of Mesenchymal Glioblastoma Stem-like Cells in Hypoxic Niches
2016
Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation
2005
Primary brain tumours in adults
2012 Standout
IDH1 and IDH2 Mutations in Gliomas
2013
Glioblastomas with an Oligodendroglial Component: A Pathological and Molecular Study
2001
Molecular Genetics of Brain Tumors
1999
Specificity and mechanism of action of some commonly used protein kinase inhibitors
2000 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
“Juvenile” Xanthogranuloma
2001
Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice
2007 StandoutNobel
Guiding intracortical brain tumour cells to an extracortical cytotoxic hydrogel using aligned polymeric nanofibres
2014
Mutations in SUFU predispose to medulloblastoma
2002 Standout
PTEN expression is maintained in sporadic colorectal tumours
2001
Brain Tumors
2001 Standout
Tumorigenesis and the angiogenic switch
2003 Standout
Use of an Orthotopic Xenograft Model for Assessing the Effect of Epidermal Growth Factor Receptor Amplification on Glioblastoma Radiation Response
2006
Novel SN-38–Incorporating Polymeric Micelles, NK012, Eradicate Vascular Endothelial Growth Factor–Secreting Bulky Tumors
2006
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
Spindle Cell Oncocytoma of the Adenohypophysis
2005
Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma
2008 StandoutNobel
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity
2016 Science
Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression
2014 StandoutNobel
The extracellular matrix: A dynamic niche in cancer progression
2012 Standout
EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance
2019 StandoutNobel
Electrosprayed nanoparticles and electrospun nanofibers based on natural materials: applications in tissue regeneration, drug delivery and pharmaceuticals
2014 Standout
Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations.
1999
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
1998 StandoutScience
Opsoclonus in Adults
1986
Array Comparative Genomic Hybridization Identifies Genetic Subgroups in Grade 4 Human Astrocytoma
2005
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
2001 Standout
PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1cell cycle entry
2005
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Regulation ofKEAP1expression by promoter methylation in malignant gliomas and association with patient’s outcome
2011
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme
2005
The 2007 WHO Classification of Tumours of the Central Nervous System
2010 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression
2001
Polyclonal Origin of Colonic Adenomas in an XO/XY Patient with FAP
1996 Science
Possible Future Issues in the Treatment of Glioblastomas: Special Emphasis on Cell Migration and the Resistance of Migrating Glioblastoma Cells to Apoptosis
2005
Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene
1986 StandoutNobel
Oxidative and Inflammatory Events in Prion Diseases: Can They Be Therapeutic Targets?
2019
Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
2008
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.
1999
Epidemiologic and Molecular Prognostic Review of Glioblastoma
2014 Standout
Physiology of Microglia
2011 Standout
Microvessel Density as a Prognostic Factor in Women with Breast Cancer
2004
Works of Stephen Hunter being referenced
Overexpression of MBD2 in Glioblastoma Maintains Epigenetic Silencing and Inhibits the Antiangiogenic Function of the Tumor Suppressor Gene BAI1
2011
Intrasellar Pituicytoma in a Patient With Other Endocrine Neoplasms
2001
Y chromosome loss in esophageal carcinoma: An in situ hybridization study
1993
Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion
2004
Immunohistochemical Demonstration of Isocitrate Dehydrogenase 1 (IDH1) Mutation in a Small Subset of Prostatic Carcinomas
2013
Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis
2011
Tumor angiogenesis as a prognostic factor in oral cavity tumors
1994
Genetic Markers in Glioblastoma: Prognostic Significance and Future Therapeutic Implications
2003
Differential Expression between Pilocytic and Anaplastic Astrocytomas: Identification of Apolipoprotein D as a Marker for Low-Grade, Non-Infiltrating Primary CNS Neoplasms
2002
Reliability of Differential PCR for the Detection of EGFR and MDM2 Gene Amplification in DNA Extracted from FFPE Glioma Tissue
1995
Solitary Intracerebral Juvenile Xanthogranuloma
1997
Analysis of Epidermal Growth Factor Receptor Gene Amplification and Alteration in Stereotactic Biopsies of Brain Tumors
1995
Alterations in molecular pathways of diffusely infiltrating glial neoplasms: application to tumor classification and anti-tumor therapy (Review)
2003
Glioblastoma with Oligodendroglioma Component (GBM ‐O ): Molecular Genetic and Clinical Characteristics
2013
Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation.
1999
Opsoclonus — a cerebellar disorder?
1981
Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion
2008
Pseudopalisades in Glioblastoma Are Hypoxic, Express Extracellular Matrix Proteases, and Are Formed by an Actively Migrating Cell Population
2004
Analysis of Epidermal Growth Factor Receptor Gene Amplification and Alteration in Stereotactic Biopsies of Brain Tumors
1995
Variant Creutzfeldt-Jakob Disease Death, United States
2005